Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases
AbstractBackground The prognostic factors for patients with pure ovarian immature teratoma (POIT) and the role of adjuvant chemotherapy in stage IA G2-G3 and IB-IC POIT remains controversial.Methods We conducted a retrospective study of 155 POIT patients treated in our hospital between 2000 and 2022...
Main Authors: | Sijian Li, Xinyue Zhang, Tianyu Zhang, Min Yin, Dongyan Cao, Yang Xiang, Jiaxin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2273984 |
Similar Items
-
Role of Adjuvant Chemotherapy in Stage I Pure Ovarian Immature Teratoma: A Systematic Review and Meta-Analysis
by: Sijian Li, et al.
Published: (2023-03-01) -
Early stage ovarian immature teratoma, surveillance or chemotherapy after surgery? A propensity score matched analysis
by: Xinyue Zhang, et al.
Published: (2022-04-01) -
Growing Teratoma Syndrome with Synchronous Gliomatosis Peritonei during Chemotherapy in Ovarian Immature Teratoma: A Case Report and Literature Review
by: Sijian Li, et al.
Published: (2022-09-01) -
Immature ovarian teratoma with pseudo-Meigs syndrome and gliomatosis peritonei
by: Taichi Fukuzawa, et al.
Published: (2022-06-01) -
Ovarian Immature Teratoma Associated with Pregnancy
by: Smita Chandra, et al.
Published: (2019-04-01)